Cybin to Present at the Jefferies Healthcare Conference

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 24, 2024

LYCRA® Brand Launches New Customizable Fit Solution at Kingpins Amsterdam • Stanford Medicine Children's Health Welcomes New Chief of the Division of Abdominal Transplantation • Austin Woman Sues Apartment Complex Following Sexual Assault by Intruder • World of Hyatt Elevates Luxury Portfolio by Adding More Than 700 Boutique and Luxury Hotels and Villas from Mr & Mrs Smith • D'FESTA LA Brings the Best of K-Pop to the US • Sunday Swagger Expands Product Line with Bold New Designs and Limited Editions for Spring • Transition Industries LLC and JAPAMA announce public-private partnership to develop innovative and environmentally responsible w • Pediatric Cancer Patients Declare "No Cape" the Winner in New Superhero Survey • MAKO Medical Partners with Rebuilding Together to Restore Home for U.S. Military Veteran • Compass Group Reinforces Commitment to Reduce Food Waste on 8th Annual Stop Food Waste Day • TEAMSTERS LOCAL 705 MEMBERS WIN RACIAL DISCRIMINATION LAWSUIT AGAINST DHL EXPRESS • Kide Science Is Named an Approved Preschool Curriculum for the State of Missouri • Nike Boys Basketball Camp at Bethune-Cookman University Welcomes Head Coach Reggie Theus • National Volunteer Week: Storyteller Shares the Joy of Reading with Kentucky Families • Hithium Hosts Roundtable at the BNEF Summit New York, Discussing Next Generation Battery Energy Storage System • Goldman Sachs Executives Empower Military Children through Education • Boeing partners with Saskatchewan Indian Institute of Technologies to elevate Indigenous education • Blue Shield of California's Award-Winning Wellvolution Now Offers Services to Prevent and Treat Musculoskeletal Pain and Injurie • Texas Home Sales Remain Steady in the First Quarter of 2024 • Lingokids Named One of TIME's Best EdTech Companies of 2024

Cybin to Present at the Jefferies Healthcare Conference

TORONTO , June 01 /Businesswire/ - Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will present at the Jefferies Healthcare Conference taking place in New York City, NY from June 7-9, 2023.

Mr. Drysdale’s presentation will be webcast live on Friday, June 9, 2023 at 8:00 a.m. ET. To listen to the event, please click here to access the webcast. The archived webcast will also be available on the Company’s investor relations website on the Events & Presentations page.

About Cybin

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions.

Cybin’s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches and treatment regimens. The Company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds.

Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For company updates and to learn more about Cybin, visit www.cybin.com or follow the team on Twitter, LinkedIn, YouTube and Instagram.